Guardant Health CIO Kalia Kumud sold 4,000 shares at $158.05 per share in an open-market transaction dated 2026-09-11. Kumud retained 39,794 shares afterward, while the sale represented about 9.1% of the prior holding, giving investors the disclosed scale and resulting position.
Key Highlights
- The transaction was dated 11 September 2026 and reported SEC transaction code S.
- Kalia Kumud held 39,794 Guardant Health shares after the transaction.
- The sale represented about 9.1% of Kumud’s prior share holding.
Kalia Kumud, Guardant Health, Inc.’s (NASDAQ: GH) chief information officer, sold 4,000 shares at $158.05 per share.
Sale Dated 11 September 2026
The transaction was dated 11 September 2026. The filing reported SEC transaction code S.
Remaining Guardant Health Position
Kumud held 39,794 Guardant Health shares after the transaction. The 4,000 shares sold represented about 9.1% of Kumud’s prior share holding. The 39,794 figure measures the remaining position after the sale, while the 9.1% figure is measured against the prior holding. Transaction code S denotes an open-market or private sale.
FAQs
Q: How many Guardant Health shares did Kalia Kumud sell?
A: Guardant Health CIO Kalia Kumud sold 4,000 shares at $158.05 per share. The filing reported the transaction on 11 September 2026 with SEC transaction code S.
Q: What was the impact of the Guardant Health insider sale?
A: Kumud held 39,794 Guardant Health shares after the transaction. The sale represented about 9.1% of the prior share holding, according to the filing dated 11 September 2026.
Q: What does transaction code S mean for Guardant Health stock?
A: SEC transaction code S was reported for the transaction. In this filing, it accompanied Kalia Kumud’s sale of 4,000 Guardant Health shares at $158.05 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.